Ticagrelor is one of the most recent antiplatelet agents used to inhibit platelet aggregation
via blocking the ADP receptors of the subtype P2Y 12. It belongs to the non-thienopyridine …

Five process-related impurities were detected in the range of 0.08-0.22% in ticagrelor
laboratory batches by HPLC and LC–MS methods. These impurities were named as TIC Imp …

Ticagrelor is a direct-acting and reversible P2Y 12-adenosine diphosphate (ADP) receptor
blocker used as antiplatelet drug. Forced degradation under various stress conditions was …

The purpose of this study is to develop and validate a spectroscopic method for the
antiplatelet drug, Ticagrelor. The method was performed on Pharmaco-model of UV …

The current investigation was carried out to develop and validate a fairly simple, accurate,
precise, reproducible and robust RP-HPLC method for the estimation of Ticagrelor …

Sensitive, accurate and precise square-wave voltammetric method was developed and
validated for determination of a new antiplatelet drug ticagrelor in drug substance using …

The current study was carried out to develop and validate a simple, accurate, precise,
reproducible and cost effective UV-Visible spectrophotometric method for the estimation of …

Objective: The present study was conducted to develop a simple and precise analytical
method for the estimation of ticagrelor in tablet formulation. Methods: Reverse Phase HPLC …

Objective The current treatment of atherosclerotic coronary heart disease with limus-eluting
stents can lead to incomplete endothelialization and substantial impairment of arterial …

An exquisite and efficient voltammetric sensor was developed for determination of a new
antiplatelet agent, Ticagrelor hydrochloride (TIC· HCl). Mn x Fe 3-x O 4 nanoparticles (x= 0.0 …